<code id='C662B68EF8'></code><style id='C662B68EF8'></style>
    • <acronym id='C662B68EF8'></acronym>
      <center id='C662B68EF8'><center id='C662B68EF8'><tfoot id='C662B68EF8'></tfoot></center><abbr id='C662B68EF8'><dir id='C662B68EF8'><tfoot id='C662B68EF8'></tfoot><noframes id='C662B68EF8'>

    • <optgroup id='C662B68EF8'><strike id='C662B68EF8'><sup id='C662B68EF8'></sup></strike><code id='C662B68EF8'></code></optgroup>
        1. <b id='C662B68EF8'><label id='C662B68EF8'><select id='C662B68EF8'><dt id='C662B68EF8'><span id='C662B68EF8'></span></dt></select></label></b><u id='C662B68EF8'></u>
          <i id='C662B68EF8'><strike id='C662B68EF8'><tt id='C662B68EF8'><pre id='C662B68EF8'></pre></tt></strike></i>

          Home / fashion / comprehensive

          comprehensive


          comprehensive

          author:Wikipedia    Page View:7313

          Editor’s note: A recording of the event is embedded below.

          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

          advertisement

          Featured Speakers

          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In